Financial & competing interests disclosure
RP Blankfield has a patent pending for the concept that one can use markers of fluid retention to gauge the cardiovascular risk of a drug. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.